Instrument Inactif

Communiqués Adamas Pharmaceuticals, Inc.

Actions

ADMS

US00548A1060

Recherche biotechnologique et médicale

Communiqués

24/11/21	Adamas Pharmaceuticals : Completion of Acquisition or Disposition of Assets - Form 8-K	PU
24/11/21	ADAMAS PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	AQ
23/11/21	Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Adamas Pharmaceuticals Tender Offer	AQ
11/11/21	Adamas: Q3 Earnings Snapshot	AQ
10/11/21	ADAMAS PHARMACEUTICALS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
12/10/21	ADAMAS PHARMACEUTICALS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adamas Pharmaceuticals, Inc. - ADMS	BU
12/10/21	Adamas Pharmaceuticals : Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio - Form 8-K	PU
12/10/21	ADAMAS PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
11/10/21	Adamas Pharmaceuticals : Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio	AQ
08/10/21	Adamas Pharmaceuticals : Announces New Employment Inducement Grants	BU
01/10/21	Adamas Pharmaceuticals : Named 2021 Finalist in the New Therapeutics Category of the UCSF Health Awards	BU
16/09/21	Adamas Pharmaceuticals : Announces GOCOVRI Presentations at the Upcoming International Parkinson and Movement Disorder Society’s (MDS) Congress	BU
10/09/21	Adamas Pharmaceuticals : Announces New Employment Inducement Grants	BU
30/08/21	Adamas Pharmaceuticals : to Present at Upcoming September Investor Conferences	BU
13/08/21	Adamas Pharmaceuticals : Announces New Employment Inducement Grant	BU
09/08/21	Adamas: Q2 Earnings Snapshot	AQ
09/08/21	ADAMAS PHARMACEUTICALS INC : Results of Operations and Financial Condition (form 8-K)	AQ
09/08/21	ADAMAS PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
09/08/21	Adamas Pharmaceuticals : Reports Second Quarter 2021 Financial Results	BU
02/08/21	Adamas Pharmaceuticals : to Announce Second Quarter Financial Results and Host Conference Call on August 9, 2021	BU
22/07/21	Adamas Pharmaceuticals : Announces Issuance of New Patents for GOCOVRI and ADS-4101	BU
09/07/21	Adamas Pharmaceuticals : Announces New Employment Inducement Grant	BU
08/07/21	Adamas Pharmaceuticals : to Present at Upcoming William Blair Biotech Focus Conference	BU
23/06/21	Adamas Pharmaceuticals : to Present at Upcoming SVB Leerink CNS Forum	BU
11/06/21	Adamas Pharmaceuticals : Announces New Employment Inducement Grant	BU